Global PET-CT Scanning Services Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

PET-CT Scanning Services Market Analysis

The PET-CT scanning services market is witnessing significant growth, driven by advancements in medical imaging technology and the rising prevalence of chronic and lifestyle diseases such as cancer, cardiovascular conditions, and neurological disorders. Positron Emission Tomography-Computed Tomography (PET-CT) combines the metabolic imaging capabilities of PET with the anatomical clarity of CT, enabling early diagnosis, precise treatment planning, and improved patient outcomes. The integration of AI-driven analytics and high-resolution imaging technologies has further enhanced diagnostic accuracy, making PET-CT an indispensable tool in modern healthcare.

Technological advancements such as augmented whole-body scanning via magnifying PET (AWSM-PET) and ultra-fast digital PET/CT scanners have improved image clarity, system sensitivity, and operational efficiency. In addition, the introduction of mobile PET/CT units has expanded accessibility, particularly in remote or underserved areas. These innovations are addressing the growing demand for non-invasive, efficient diagnostic solutions.

PET-CT Scanning Services Market Size

The global PET-CT Scanning Services market size was valued at USD 2.14 billion in 2024 and is projected to reach USD 3.10 billion by 2032, with a CAGR of4.76 % during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

PET-CT Scanning Services Market Trends

“Increasing Adoption of Mobile PET/CT Units”

One significant trend in the PET-CT scanning services market is the increasing adoption of mobile PET/CT units, which are transforming healthcare accessibility and efficiency. Mobile PET/CT scanners, such as CDL Nuclear Technologies' dedicated cardiac PET/CT trailer launched in 2024, are designed to bring advanced imaging services directly to medical facilities, including those in underserved or remote areas. This innovation eliminates the need for patients to travel to centralized imaging centers, thus reducing logistical challenges and wait times. These mobile units are particularly valuable for cardiac imaging, offering precise diagnostic capabilities for conditions such as coronary artery disease. Furthermore, the integration of advanced technologies, including AI-enhanced analytics and ultra-fast scanning capabilities, within these mobile solutions ensures high diagnostic accuracy. This trend addresses the rising demand for accessible and efficient diagnostic tools and aligns with the broader goals of improving healthcare outcomes and optimizing resource allocation in diverse healthcare settings.

Report Scope and PET-CT Scanning Services Market Segmentation  

PET-CT Scanning Services Market Definition

PET-CT Scanning Services refer to medical imaging services that combine Positron Emission Tomography (PET) and Computed Tomography (CT) technologies into a single, integrated scan. PET-CT scans provide detailed functional and anatomical information by capturing metabolic activity through PET imaging and structural details through CT imaging.

PET-CT Scanning Services Market Dynamics

Drivers

• Increasing Incidence of Cancer

The rising prevalence of cancer worldwide is a significant driver for the PET-CT scanning services market. As cancer cases increase, the demand for diagnostic tools that can accurately detect and monitor the progression of the disease becomes more critical. PET-CT scans are widely recognized for their ability to identify tumors, assess the extent of cancer, and monitor treatment effectiveness. For instance, PET-CT scans play a crucial role in detecting early-stage cancers such as lung and breast cancer, allowing for timely interventions and better outcomes. The World Health Organization (WHO) reports that cancer is one of the leading causes of death globally, highlighting the growing need for these advanced imaging services. Consequently, healthcare providers and hospitals are increasingly adopting PET-CT scanning services to address the surge in cancer diagnoses, thereby fueling market growth.

• Growing Geriatric Population

The aging population is contributing significantly to the demand for PET-CT scanning services. As people age, they become more susceptible to chronic diseases, including cancer, cardiovascular disorders, and neurological conditions. This demographic shift is driving healthcare systems to adopt advanced diagnostic technologies to manage the growing burden of age-related diseases. PET-CT scans are particularly beneficial in detecting and monitoring conditions common in older adults, such as Alzheimer’s disease, cardiac issues, and malignancies. In fact, research has shown that PET-CT imaging helps identify early signs of Alzheimer’s, enabling proactive management of the disease. With an increasing number of elderly individuals worldwide, the demand for accurate and non-invasive diagnostic tools such as PET-CT scanners is expected to rise. This trend is propelling the growth of the PET-CT scanning services market as healthcare providers seek to meet the needs of this expanding demographic.

Opportunities

• Increasing Technological Advancements in Imaging

Continuous advancements in PET-CT technology are opening new opportunities for growth in the PET-CT scanning services market. Innovations such as higher image resolution, faster scanning times, and the integration of artificial intelligence (AI) are significantly improving the diagnostic capabilities of PET-CT systems. For instance, AI-powered image analysis can enhance the accuracy of tumor detection, enabling early diagnosis and better treatment planning. One instance is the development of time-of-flight (TOF) PET scanners that provide faster and more accurate images, reducing the need for repeat scans. As these technological advancements reduce scan times and improve image clarity, healthcare facilities are increasingly adopting state-of-the-art PET-CT machines to offer superior diagnostic services. This shift toward more efficient and precise imaging techniques is expected to drive demand for PET-CT scanning services, presenting a significant market opportunity for service providers who invest in the latest technologies.

• Rising Demand for Personalized Medicine

The growing focus on personalized medicine is another key market opportunity for PET-CT scanning services. Personalized medicine aims to tailor treatments to individual patients based on their unique genetic, environmental, and lifestyle factors, and PET-CT imaging plays a crucial role in this approach. PET-CT scans provide detailed insights into the biological processes of diseases, such as cancer or cardiovascular conditions, helping clinicians to identify the most effective treatment plans for each patient. For instance, PET-CT scans can help oncologists determine the aggressiveness of a tumor and evaluate the patient's response to specific therapies, guiding decisions about the best course of action. As the healthcare industry continues to prioritize personalized treatment plans, the demand for advanced imaging technologies such as PET-CT will grow, presenting significant opportunities for the market. This trend is driving an increased need for accurate and detailed diagnostic services, expanding the scope of PET-CT scanning services.

 Restraints/Challenges

• High Cost of Equipment and Maintenance

One of the most significant challenges in the PET-CT scanning services market is the high cost of equipment and maintenance. PET-CT scanners are advanced, cutting-edge medical devices that require substantial financial investment for purchase, installation, and regular maintenance. The initial cost of a single PET-CT scanner can range from hundreds of thousands to millions of dollars, making it unaffordable for smaller healthcare facilities, particularly in developing countries. For instance, in nations with limited healthcare budgets such as parts of Africa or Southeast Asia, many hospitals cannot afford to purchase these devices or maintain them properly due to their high operational costs. The expense extends beyond just the purchase of the machine; ongoing maintenance, upgrades, and specialized training for personnel add to the overall financial burden. This results in PET-CT scanners being predominantly available in larger, well-funded hospitals and specialized clinics, limiting their widespread availability and accessibility. As a result, this financial barrier restricts the adoption of PET-CT scanning services in less affluent areas, hindering the overall market growth.

• Lack of Skilled Professionals

A major challenge for the PET-CT scanning services market is the lack of skilled professionals required to operate and interpret the results from PET-CT scanners. These systems require highly trained technicians, radiologists, and nuclear medicine specialists who are capable of operating the equipment and accurately interpreting the images produced. In many regions, especially in rural or developing areas, there is a shortage of such qualified personnel, which results in challenges related to the quality and efficiency of PET-CT scanning services. For instance, in countries such as India or parts of Latin America, there is a growing demand for skilled professionals to operate PET-CT systems, but the supply of trained personnel does not meet the demand. This leads to increased errors in scans or delays in diagnosis due to improper handling, ultimately impacting the reliability of these services. With the growing complexity of the systems and the need for accurate image interpretation to diagnose critical conditions such as cancer, cardiovascular diseases, and neurological disorders, the shortage of skilled professionals poses a significant challenge to the quality of PET-CT scanning services, limiting their potential to improve patient outcomes.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

PET-CT Scanning Services Market Scope

The market is segmented on the basis of type, application, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Positron Emission Tomography (PET) Scanner
• X-Ray Computed Tomography (CT) Scanner

Application

• Oncology
• Cardiology
• Neurology
• Others

End User

• Hospitals
• Diagnostic Centers
• Research Institutes

PET-CT Scanning Services Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, application, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the PET-CT scanning services market, primarily driven by its aging population and the rising prevalence of chronic disorders. The growing demand for early and accurate diagnostic solutions for conditions such as cancer, cardiovascular diseases, and neurological disorders has fueled the adoption of PET-CT scanning services. In addition, the region benefits from well-established healthcare infrastructure and significant investments in advanced medical technologies, further supporting market growth. These factors collectively ensure North America's dominance in the PET-CT scanning services industry.

Europe is projected to experience fastest growth in the PET-CT scanning services market during the forecast period. This growth is attributed to the region's increasing population, coupled with lifestyle shifts influenced by modern societal trends. As chronic diseases such as cancer and cardiovascular conditions become more prevalent due to these lifestyle changes, the demand for advanced diagnostic tools such as PET-CT scanners continues to rise. In addition, the emphasis on improving healthcare infrastructure and access across various European countries further supports the market's expansion.

 The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

PET-CT Scanning Services Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

PET-CT Scanning Services Market Leaders Operating in the Market Are:

• TOSHIBA CORPORATION (Japan)
• General Electric Company (U.S.)
• Hitachi, Ltd. (Japan)
• Siemens (Germany)
• Positron (U.S.)
• Kindsway Biotech (China)
• Mediso Ltd. (Hungary)
• Koninklijke Philips N.V. (Netherlands)
• Shimadzu Corporation (Japan)
• PerkinElmer (U.S.)
• FUJIFILM Holdings Corporation (Japan)

Latest Developments in PET-CT Scanning Services Market

• In June 2024, a breakthrough technology called Augmented Whole-Body Scanning via Magnifying PET (AWSM-PET) was introduced, showcasing remarkable improvements in image clarity and system sensitivity for clinical whole-body PET/CT imaging
• In April 2024, CDL Nuclear Technologies unveiled its innovative Mobile Dedicated Cardiac PET/CT Trailer, designed to revolutionize cardiac care by delivering advanced PET/CT imaging services directly to medical facilities on flexible schedules
• In February 2023, United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, participated as a Platinum partner at Arab Health 2023 in Dubai, U.A.E., showcasing cutting-edge technologies, including the HD TOF PET/MR uPMR 790, uCT 960+ cardiac CT scanner, uMI 780 digital PET/CT scanner, uMR 680 MRI system, and the uDR 380i Pro compact mobile DR system
• In April 2022, Royal Victoria Regional Health Centre (RVH) implemented new medical imaging technology, enabling earlier detection of certain cancers
• In May 2021, GE Healthcare acquired Zionexa, a leading innovator in in-vivo biomarkers for oncology and neurology, to expand its biomarker portfolio, including Cerianna (fluoroestradiol F-18), an FDA-approved PET imaging agent used to detect estrogen receptor (ER) positive lesions in metastatic breast cancer for personalized treatment planning

SKU-60298